REMICADE

Swiss trademark · 459326 · Word mark · In force

Register entry

Registration number
459326
Application number
08024/1998
Status
In force
Type
Word mark
Filed
Sep 29, 1998
Registered
Mar 4, 1999
Published
Apr 9, 1999
Protected until
Sep 29, 2028
Priority
09.07.1998 US
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Verbindungen zur Behandlung von Autoimmunkrankheiten.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 4, 2023

    Agent removed

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich (removed)

    Published in Swissreg on 04.05.2023

  2. Oct 19, 2017

    Renewed

    Published in Swissreg on 19.10.2017

  3. Jun 22, 2012

    Holder’s address changed

    Owner
    Centocor Ortho Biotech, Inc., 800/850 Ridgeview Drive, Horsham, PA 19044, USA → Janssen Biotech, Inc., 800 Ridgeview Drive, Horsham, Pennsylvania 19044, USA

    Published in Swissreg on 22.06.2012

  4. Dec 14, 2009

    Address changed

    Owner
    Centocor, Inc., 200 Great Valley Parkway, Malvern (PA 19355), USA → Centocor Ortho Biotech, Inc., 800/850 Ridgeview Drive, Horsham, PA 19044, USA

    Published in Swissreg on 14.12.2009

  5. Sep 17, 2008

    Renewed

    Published in Swissreg on 17.09.2008

  6. Dec 3, 2007

    Agent’s address changed

    Representative
    E. Blum & Co., Patentanwälte, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in the SOGC no. 234 of 03.12.2007

  7. Apr 9, 1999

    Registered

    Published in the SOGC no. 68 of 09.04.1999

Parties

Holder

Janssen Biotech, Inc.

800 Ridgeview Drive, Horsham, Pennsylvania 19044, US

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.